The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients
A. Taniguchi et al., The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients, METABOLISM, 49(8), 2000, pp. 1001-1005
Using the minimal model approach shown by Bergman, our group had previously
shown 2 variants among non-obese mildly diabetic patients, one with normal
insulin sensitivity and the other with insulin resistance, The present stu
dy examines whether these 2 variants exist in the ordinary Japanese non-ins
ulin-dependent diabetes mellitus (NIDDM) population and compares the clinic
al profile between the 2 discrete forms of NIDDM. In addition, we investiga
ted the factors responsible for insulin resistance observed in Japanese NID
DM populations. One hundred eleven untreated Japanese NIDDM subjects (fasti
ng glucose < 10 mmol/L) were assessed for insulin action (homeostasis model
assessment [HOMA-IR] = fasting serum insulin (mu U/mL) x fasting plasma gl
ucose (mmol/L)/22.5) and the fasting lipid profile. Sixty percent of these
patients had normal insulin sensitivity (HOMA-IR < 2.5). The insulin-resist
ant patients had higher serum cholesterol (188.1 +/- 5.2 v 182.2 +/- 3.9 mg
/dL, P > .05) and low density lipoprotein (LDL) cholesterol (501.2 +/- 16.7
v 469.4 +/- 14.8 mg/dL, P > .05) than the insulin-sensitive patients, but
the difference was not statistically significant, In contrast, the former g
roup had a significantly higher body mass index ([BMI] 26.6 +/- 0.8 v 21.7
+/- 0.4 kg/m(2), P < .0001) and higher serum triglycerides (181.0 +/- 16.4
(range, 79 to 545) v 95.1 +/- 4.1 (range, 36 to 204) mg/dL, P < .0001) and
lower high-density lipoprotein (HDL) cholesterol (47.2 +/- 1.7 v 58.2 +/- 2
.5 mg/dL, P < .005) than the latter group. HOMA-IR was related to the BMI.
Fifteen of 17 (88%) NIDDM patients with a BMI greater than 27.0 were insuli
n-resistant, whereas 35 of 38 (92%) NIDDM patients with a BMI less than 21.
5 were insulin-sensitive. In the midrange BMI (21.5 to 27.0 kg/m2), patient
s were equally likely to be insulin-resistant or insulin-sensitive. Analysi
s of the midrange BMI group showed that HOMA-IR was associated with serum t
riglycerides (P < .0001) but not with the BMI. These data suggest the follo
wing conclusions: (1) Japanese NIDDM patients can be classified into 2 popu
lations, one with normal insulin sensitivity and the other with insulin res
istance; (2) NIDDM patients with normal insulin action have a low cardiovas
cular disease risk factor, whereas those with insulin resistance have a mar
kedly increased cardiovascular disease risk factor; and (3) the BMI and ser
um triglyceride level per se are associated with insulin action in Japanese
NIDDM populations. Copyright (C) 2000 by W.B. Saunders Company.